PCV51 PROJECTED LDL-C REDUCTION AND GOAL ATTAINMENT BY SWITCHING PATIENTS TO DUAL INHIBITION THERAPY (EZETIMIBE/SIMVASTATIN 10/20MG) IN SPAIN

✍ Scribed by G Nocea; G Davies; MT Caloto; E Alemao; D Yin; J Cook

• Book ID: 118607732
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 63 KB
• Volume: 8
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)67462-1